Author: Neubauer Lab

  • 7th Annual Meeting of the International Cytokine & Interferon Society

    From the 20th – 23rd October members of the Moriggl lab were excited to join the 7th Annual Meeting of the International Cytokine & Interferon Society that took place in the beautiful Hofburg in Vienna.

    Heidi presenting her research on the beautiful stage

    Our group was represented by well-received posters from Tobias Suske, Anna Orlova, Christina Maria Wagner and Helena Sorger. A highlight of the conference was an interesting selected short talk by Heidi Neubauer about the gain-of-function STAT5B N642H mutation as a driver of mature T cell leukemia/ lymphoma.

  • Wachaumarathon 2019

    Happy after completing the unique route from Emmersdorf to Dürnstein.

    To show our great team-working spirits, 3 members of the Moriggl lab (+ Lindsay Kosack from the CeMM) completed a scenic relay marathon in the Wachau. Thanks Anna for organizing!

  • International Symposium on T cells and T-cell lymphomas in Essen

    Members of the Moriggl group travelled to Essen, Germany to join the Symposium on T cells and T-cell lymphomas.

    Helena presenting a poster at the Symposium.

    Helena Sorger and Tobias Suske presented their PhD research in poster format while Heidi Neubauer gave an interesting talk on her T cell project.

    Heidi giving her talk

    Thank you to the CONTROL-T consortium for organising this inspiring symposium!

  • Business Run 2019

    Anticipating the “Startpfiff” of the 2019 Business Run.

    To demonstrate the fitness of the Moriggl lab, we participated at the Wien Energie Business Run 2019 and made it successfully into the finish line.

  • Spin-Off Fellowship for Anna Orlova

    Targeting STAT5 Oligomerization in Leukemia

    Due to her remarkable research efforts, Dr. Anna Orlova was awarded with the FFG Spin-Off Fellowship which enables her to form her own group within the Moriggl lab. In the course of the fellowship, Anna wants to target cancerous STAT5 oligomerization in Acute Myeloid Leukemia. We are impressed by this great accomplishment!

    Read more about Anna’s research here.